Hospital floor, person with mask and protection suit, walking, unfixing the mask, two more people in the back, 06/2015, (General, Photography, Doctor/Physician, Hospital)

Diagnostic testing

Syndromic testing with QIAstat-Dx

To support the efforts for accessible testing to meet the demands of the COVID-19 outbreak, QIAGEN has developed the QIAstat-Dx Respiratory SARS-CoV-2 Panel. This version of our multiplex syndromic cartridge enables detection of the SARS-CoV-2 virus that causes COVID-19 in addition to 20+ other respiratory pathogens.*

QIAstat-Dx, QIAstat-Dx analyzer, syndromic testing, instrument, cartridge QIAstat-Dx, QIAstat-Dx analyzer, syndromic testing, instrument, cartridge, technician, woman, lab tech, lab, laboratory
*The number of targets/pathogens detected by the QIAstat-Dx Respiratory SARS-CoV-2 Panels is different in different countries.
QIAseq Targeted Methyl Panels
Increase lab throughput with our innovative liquid sample prep

The artus SARS-CoV-2 Prep&Amp UM Kit is an innovative liquid-based kit for SARS-CoV-2 detection. With fewer and simpler workflow steps, you can accelerate your lab's turnaround time while decreasing plastic usage, cost and hands-on time. With artus Prep&Amp, you integrate the sample preparation and the detection in a streamlined liquid workflow - getting quick results in 90 minutes.

A new tool in the fight against COVID-19
Cell mediated immunity is an enduring and reliable marker of the adaptive immune response after COVID-19 vaccination. T cell responses to SARS-CoV-2 decline more slowly than antibody responses and may provide a more sensitive way to monitor immune responses to SARS-CoV-2 vaccination than serological assays alone. QuantiFERON SARS-CoV-2 features trusted QuantiFERON technology to measure cell mediated immune response after SARS-CoV-2 vaccination.
QuantiFERON SARS-CoV-2 CE-IVD blood collection tubes (BCT)
scientist, laboratory, labworker, check, reaserch, monitor, round, machine, instrument, female asian scientist in a lyb inviroment wearing a mask
QIAGEN support in testing protocols for emergency use

QIAGEN supports several testing protocols, including U.S. CDC, WHO, China CDC and Japan CDC, by providing test components, mid- to high-throughput automation solutions, and a multiplex syndromic detection solution. 

Product availability varies by country. Please contact your country representative or complete the support request form for further details. Please also review the protocols themselves for alternative solutions from other suppliers.

For QIAcube classic information please visit our resource hub.
RNA extraction solutions

Given the current public health emergency with COVID-19, QIAGEN and other companies are facing unprecedented demand for viral RNA isolation solutions. QIAGEN has developed dedicated solutions for viral RNA isolation that have been optimized for maximum sensitivity and reproducibility. 

We recognize that currently, scientists are seeking to use various QIAGEN kits, such as RNeasy, for SARS-CoV-2 RNA isolation from respiratory samples. It is critical to note that these kits have not been designed for isolating viral RNA, and performance of each kit varies. The user must consult the product-specific handbook or user manual. We strongly recommend using only dedicated RNA isolation products for SARS-CoV-2, such as those listed below:

Solutions authorized for use for COVID-19 testing in some regions (please check local regulations)

group of scientist, talk, discussion, laboratory, diversity, wearing masks
For QIAcube classic information please visit our resource hub.

Tailored oligonucleotides for SARS-CoV-2 detection

In our effort to support the detection of the SARS-CoV-2 virus, OEM by QIAGEN has ramped up the production of SARS-CoV-2 specific primers and probes. We provide customized oligos defined by our customers, as well as those mentioned in protocols recommended by WHO and the CDC. To meet the high demands, we are currently prioritizing the orders of SARS-CoV-2 specific oligonucleotides. In addition, we have introduced pre-manufacturing of these oligonucleotides to enable quick supply and delivery. To order, please send your requests here.

How can we support your lab?
Reach a specialist about SARS-CoV-2 resources.

The QIAreach SARS-CoV-2 Antigen Test and the QIAreach Anti-SARS-CoV-2 Total Test are currently under development and are coming soon.